Forecast & Rating2 analysts currently cover GEMPHARMATECH, of which 2 give a positive rating. The average price target is ¥45.54, about 32.6% upside from the current price of ¥34.35. Coverage is limited, so the data is for reference only. Data as of Aug 20, 2026; this does not constitute investment advice.
Aug 20, 2026Price forecast
¥45.5432.58%
Forecast & RatingStrong buy
2analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 16, 2026
Forecast met0.0%
Stock price$34.35
Avg. target$21.9
High target$23
Low target$21
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.